longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BIORA THERAPEUTICS INC

BIORQ

0.00010.00% ( 0.0000 )
Delay Trading: Sep 9, 10:34:01 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • 15:00 ETBioOra and Cincinnati Children's Hospital Medical Center Partner to Advance Next-Generation CAR-T Therapy for Children with Leukaemia

    prnewswire·Apr 13 at 07:00 PM
    BIORQ0.00%BIOR0.00%
  • BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform

    biopharmadive·Apr 7 at 02:18 PM
    BIB-2.10%BIOR0.00%
  • Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness

    MorningStar·Apr 6 at 12:05 PM
    TBPH0.00%IXJ-0.28%
  • UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION | BORAY Stock News

    StockTitan·Apr 6 at 10:05 AM
    BMRN+0.18%BBH-0.31%
  • 08:50 ETInside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issue

    prnewswire·Mar 27 at 12:52 PM
    BIORQ0.00%BIOR0.00%
  • 12:07 ETBioretec Ltd's Financial Statements and Annual Report 2025 published

    prnewswire·Mar 13 at 04:08 PM
    BIORQ0.00%BIOR0.00%
  • 16:13 ETNotice of the Extraordinary General Meeting of Bioretec Ltd

    prnewswire·Mar 10 at 08:13 PM
    BIOR0.00%BIORQ0.00%
  • Bioretec Ltd's financials for Jan-Dec 2025: Net sales EUR 3,522k (-22.5% vs 2024), EBITDA EUR -8,476k. Strategy update for 2026–2028.

    Unusual Whales·Feb 13 at 08:07 AM
    BIOR0.00%BIORQ0.00%
  • Biora Therapeutics completes restructuring process, now privately held; aims to speed up BioJet™ platform development.

    Unusual Whales·May 8, 2025 at 09:52 PM
    BIORQ0.00%BIOR0.00%
  • Biora Therapeutics finishes restructuring, now privately held with funds to boost BioJet™ platform development.

    Unusual Whales·May 4, 2025 at 07:33 PM
    BIOR0.00%BIORQ0.00%
  • Biora Therapeutics exits restructuring as a private company, securing funding to advance BioJet™ platform.

    Unusual Whales·Apr 19, 2025 at 11:07 PM
    BIOR0.00%BIORQ0.00%
  • Biora Therapeutics, a privately held company, completes restructuring process for development of BioJet™ platform.

    Unusual Whales·Apr 17, 2025 at 10:32 PM
    BIOR0.00%BIORQ0.00%